FDA
-
-
-
-
-
-
-
FDA expands EVO ICL age indication to patients 21 to 60 years old
-
-
-
-
-
-
-
STAAR Surgical (STAA) Announces $30 Million Share Repurchase Authorization
-
-
-
-
-
-
-
STAAR Surgical Announces Preliminary Net Sales for First Quarter 2024
-
-
-
-
-
-
-
Stifel Starts STAAR Surgical (STAA) at Hold
-
-
-
-
-
-
-
STAAR Surgical (STAA) Announces FDA Approval of EVO Visian Implantable Collamer Lenses
-
-
-
-
-
-
-
STAAR Surgical (STAA) Tops Q1 EPS by 11c, Revenues Beat
-
-
-
-
-
-
-
STAAR Surgical (STAA) Trial Design is a Lower Bar Than Anticipated - Canaccord Genuity
-
323,573 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

